Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-06-07
1996-06-04
Datlow, Philip I.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514318, 514319, 546168, 546174, 546194, 546205, A61K 3144, A61K 31445, A61K 3147
Patent
active
055233074
ABSTRACT:
A cyclic amine is defined by the formula: ##STR1## in which A is naphthyl, phenyl, quinolyl or alkyl, X is a group containing carbonyl, n is 2 or 3 and B is alkyl, halogen, phenyl or --YZ, Y being --0--, --CO-- or --NH--, Z being phenyl, naphthyl, pyridyl, alkyl or cycloalkyl. It is useful to treat a mental symptoms associated with a cerebrovascular disease.
REFERENCES:
patent: 3576810 (1971-04-01), Duncan et al.
patent: 4075346 (1978-02-01), Sasajima et al.
patent: 4101662 (1978-07-01), Ward et al.
patent: 4246268 (1981-01-01), Carr
patent: 4921863 (1990-05-01), Sugimoto et al.
Arzneimittelforschung, vol. 24, No. 4a, 1974, pp. 584-600; Hiltmann et al.
Journal Organic Chemistry, vol. 33, No. 9, 1968, pp. 3627-3632, Johnson.
Journal of Organic Chemistry, vol. 31, No. 10, 1966, pp. 3337-3342, Lynch et al.
Journal of Medicinal Chemistry, vol. 13, No. 1, 1970, pp. 1-6, Duncan et al.
Arzneimittelforschung, vol. 39, No. 4, 1989, pp. 445-450, Kaneko et al.
Japanese-United States Congress of Pharmaceutical Sciences, Dec. 2-7, 1987, p. 159, Karibe et al.
Chem. Abstract, CA (106) 213767Z, 1987, p. 645, Sugimoto et al.
Higurashi Kunizo
Ikeda Masuhiro
Kaneko Takeru
Karibe Norio
Nakamura Takaharu
Datlow Philip I.
Eisai Co. Ltd.
LandOfFree
Cyclic amine and pharmacological composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic amine and pharmacological composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic amine and pharmacological composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-383544